Publications
In Reply: Relationship Between Aneurysm Wall Enhancement in Vessel Wall Magnetic Resonance Imaging and Rupture Risk of Unruptured Intracranial Aneurysms;
Lv, N, Karmonik, C, Huang, Q & Liu, J 2019, Neurosurgery, vol. 84, no. 3, pp. E234. https://doi.org/10.1093/neuros/nyy581
Characterization of Functional Brain Connectivity towards Optimization of Music Selection for Therapy – A fMRI study AU - Wu, Katherine;
Anderson, JR, Townsend, J, Frazier, JT, Brandt, A & Karmonik, C 2019, International Journal of Neuroscience, pp. 1-9. https://doi.org/10.1080/00207454.2019.1581189
Editorial Comment;
Elizondo, RA & Koh, CJ 2019, The Journal of urology, vol. 201, no. 2. https://doi.org/10.1097/01.JU.0000552991.45779.5f
Injection of Urethral Bulking Agents;
Li, H & Westney, OL 2019, Urologic Clinics of North America, vol. 46, no. 1, pp. 1-15. https://doi.org/10.1016/j.ucl.2018.08.012
Randomized Controlled Trial of Aquablation versus Transurethral Resection of the Prostate in Benign Prostatic Hyperplasia: One-year Outcomes;
Gilling, PJ, Barber, N, Bidair, M, Anderson, P, Sutton, MA, Aho, T, Kramolowsky, E, Thomas, A, Cowan, B & Roehrborn, C 2019, Urology. https://doi.org/10.1016/j.urology.2018.12.002
Role of Patients and Parents in Pediatric Drug Development;
Tsang, VWL, West, L, Woods, C, Koh, CJ, McCune, S, Mullin, T, Smith, SR, Gaillard, S, Claverol, J, Nafria, B, Preston, J, Dicks, P & Thompson, C 2019, Therapeutic Innovation and Regulatory Science. https://doi.org/10.1177/2168479018820875
Multiple Aneurysms AnaTomy CHallenge 2018 (MATCH): Phase I: Segmentation;
Berg, P, Voß, S, Saalfeld, S, Janiga, G, Bergersen, AW, Valen-Sendstad, K, Bruening, J, Goubergrits, L, Spuler, A, Cancelliere, NM, Steinman, DA, Pereira, VM, Chiu, TL, Tsang, ACO, Chung, BJ, Cebral, JR, Cito, S, Pallarès, J, Copelli, G, Csippa, B, Paál, G, Fujimura, S, Takao, H, Hodis, S, Hille, G, Karmonik, C, Elias, S, Kellermann, K, Khan, MO, Marsden, AL, Morales, HG, Piskin, S, Finol, EA, Pravdivtseva, M, Rajabzadeh-Oghaz, H, Paliwal, N, Meng, H, Seshadhri, S, Howard, M, Shojima, M, Sugiyama, SI, Niizuma, K, Sindeev, S, Frolov, S, Wagner, T, Brawanski, A, Qian, Y, Wu, YA, Carlson, KD, Dragomir-Daescu, D & Beuing, O 2018, Cardiovascular Engineering and Technology, vol. 9, no. 4, pp. 565-581. https://doi.org/10.1007/s13239-018-00376-0
The association between physician trust and prostate-specific antigen screening: Implications for shared decision-making;
Klaassen, Z, Wallis, CJD, Goldberg, H, Chandrasekar, T, Fleshner, NE, Finelli, A, Kulkarni, GS, Detsky, AS & Satkunasivam, R 2018, Canadian Urological Association Journal, vol. 12, no. 12, pp. 395-400. https://doi.org/10.5489/cuaj.5351
The role of provider characteristics in the selection of surgery or radiation for localized prostate cancer and association with quality of care indicators;
Satkunasivam, R, Lo, M, Stern, M, Gill, IS, Fleming, S, Wu, XC, Anderson, RT, Thompson, TD & Hamilton, AS 2018, American Journal of Clinical Oncology: Cancer Clinical Trials, vol. 41, no. 11, pp. 1076-1082. https://doi.org/10.1097/COC.0000000000000442
Heterozygous deletion of chromosome 17p renders prostate cancer vulnerable to inhibition of RNA polymerase II;
Li, Y, Liu, Y, Xu, H, Jiang, G, Van der Jeught, K, Fang, Y, Zhou, Z, Zhang, L, Frieden, M, Wang, L, Luo, Z, Radovich, M, Schneider, BP, Deng, Y, Liu, Y, Huang, K, He, B, Wang, J, He, X, Zhang, X, Ji, G & Lu, X 2018, Nature Communications, vol. 9, no. 1, 4394. https://doi.org/10.1038/s41467-018-06811-z